Last update 11 Dec 2024

Thioridazine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine, 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine, 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine
+ [7]
Mechanism
5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D1 receptor antagonists(Dopamine D1 receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC21H26N2S2
InChIKeyKLBQZWRITKRQQV-UHFFFAOYSA-N
CAS Registry50-52-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Generalized anxiety disorder
US
18 Oct 1978
Schizophrenia
US
18 Oct 1978
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Unresectable Hepatocellular CarcinomaPhase 3
CN
29 Aug 2022
Diffuse Large B-Cell LymphomaPreclinical
DE
01 Dec 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
xypxpqorke(rqywuitpuc) = kiftilqcdt idzazbtvmz (gplezffwmq )
-
14 Aug 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free